Workflow
Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses FDA Approval and Commercial Launch Plans for REDEMPLO in Familial Chylomicronemia Syndrome Transcript

PresentationGood afternoon, and welcome to the Arrowhead Pharmaceuticals REDEMPLO FDA Approval Conference Call. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Arrowhead website following the conclusion of the event. I'd now like to turn the call over to Vince Anzalone, Vice President of Finance and Investor Relations at Arrowhead Pharmaceuticals. Please go ahead, Vince.Vincent AnzaloneHead of Investor Relations & VP Thank you, Tara, and thank y ...